543 Results

People

  1. Schoder
    Schoder
  2. Humm
    Humm
  3. Zelenetz
    Zelenetz
  4. Lee
    Lee
  5. Moskowitz
    Moskowitz
  6. Noy
    Noy
  7. Larson
    Larson
  8. Palomba
    Palomba
  9. Yahalom
    Yahalom
  10. Horwitz
    Horwitz

Groups

  1. Molecular Imaging and Therapy Service (543)
  2. Radiology, Department of (543)
  3. Department of Medicine (266)
  4. GSK Faculty (161)
  5. Hematologic Malignancies, Division of (153)
  6. Sloan Kettering Institute Postdocs (153)
  7. Survivorship Research (147)
  8. Center for Hematologic Malignancies (146)
  9. Epidemiology and Biostatistics (144)
  10. Medical Physics (144)
  1. "Heiko Schoder"
Formats
  1. Journal Article (263)
  2. Meeting Abstract (199)
  3. Book Section (31)
  4. Review (18)
  5. Editorial (14)
  6. Guidelines (8)
  7. Research Letter (6)
  8. Miscellaneous (3)
  9. Conference Paper (1)
Groups
  1. Molecular Imaging and Therapy Service (543)
  2. Radiology, Department of (543)
  3. Department of Medicine (266)
  4. GSK Faculty (161)
  5. Hematologic Malignancies, Division of (153)
  6. Sloan Kettering Institute Postdocs (153)

More Groups

People
  1. Heiko Schoder (543)
  2. John Humm (96)
  3. Steven Larson (93)
  4. Andrew Zelenetz (66)
  5. Nancy Lee (65)
  6. Alison Moskowitz (59)

More People

Years
  1. 2025 (11)
  2. 2024 (36)
  3. 2023 (42)
  4. 2022 (40)
  5. 2021 (51)
  6. 2020 (30)

More Years

Publications
  1. Journal of Nuclear Medicine (94)
  2. Journal of Clinical Oncology (60)
  3. Blood (59)
  4. International Journal of Radiation Oncology, Biology, Physics (41)
  5. European Journal of Nuclear Medicine and Molecular Imaging (38)
  6. Hematological Oncology (13)

More Publications

Publishers
  1. Society of Nuclear Medicine (94)
  2. Springer (78)
  3. Elsevier Inc. (67)
  4. American Society of Hematology (65)
  5. American Society of Clinical Oncology (60)
  6. Lippincott Williams & Wilkins (22)

More Publishers

Results (543)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma
    Journal Article

    Fury, M. G.; Xiao, H.; Sherman, E. J.; Baxi, S.; Smith-Marrone, S.; Schupak, K.; Gewanter, R.; Gelblum, D.; Haque, S.; Schoder, H.; more...
    Head & Neck (2016)

    Fulltext@MSK | Save
  • Prospective study of 3′-deoxy-3′-(18)F-fluorothymidine PET for early interim response assessment in advanced-stage B-cell lymphoma
    Journal Article

    Schoder, H.; Zelenetz, A. D.; Hamlin, P.; Gavane, S.; Horwitz, S.; Matasar, M.; Moskowitz, A.; Noy, A.; Palomba, L.; Portlock, C.; more...
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Feasibility of (18)F-fluoromisonidazole kinetic modeling in head and neck cancer using shortened acquisition times
    Journal Article

    Grkovski, M.; Schwartz, J.; Gönen, M.; Schöder, H.; Lee, N. Y.; Carlin, S. D.; Zanzonico, P. B.; Humm, J. L.; Nehmeh, S. A.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Novel approaches to thyroid cancer treatment and response assessment
    Journal Article

    Grewal, R. K.; Ho, A.; Schöder, H.
    Seminars in Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Pediatric sarcomas
    Book Section

    Quartuccio, N.; Wexler, L.; Schöder, H.
    In Mansi, L.; Lopci, E.; Cuccurullo, V.; Chiti, A. (Eds.) Clinical Nuclear Medicine in Pediatrics (2016)

    Fulltext@MSK | Save
  • Radiation oncology: Staging, follow-up, and planning
    Book Section

    Schoder, H.; Rimner, A.; Humm, J.
    In von Schulthess, G. K. (Eds.) Clinical Molecular Anatomic Imaging: PET/CT, PET/MR and SPECT CT. 3rd ed (2015)

    Fulltext@MSK | Save
  • Can metabolic tumor volume further risk stratify patients eligible for treatment deintensification in the newly proposed HPV-associated oropharyngeal cancer staging system?
    Meeting Abstract

    Romesser, P. B.; Ong, L.; Wong, R. J.; Sherman, E. J.; Riaz, N.; McBride, S. M.; Katabi, N.; Schoder, H.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Initial results of US intergroup trial of response-adapted chemotherapy or chemotherapy/radiation therapy based on PET for non-bulky stage I and II Hodgkin lymphoma (HL) (CALGB/Alliance 50604)
    Meeting Abstract

    Straus, D. J.; Pitcher, B.; Kostakoglu, L.; Grecula, J. C.; Hsi, E. D.; Schoder, H.; Jung, S. H.; Popplewell, L. L.; Chang, J. E.; Moskowitz, C. H.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • TARC predicts PET-normalization and event free surival in relapsed/refractory Hodgkin lymphoma patients treated with brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Cho, S.; Fleisher, M.; Woo, K. M.; Zhang, Z. G.; Fox, S.; McCall, S. J.; Schoder, H.; Yahalom, J.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma
    Journal Article

    Chhabra, A.; Ong, L. T.; Kuk, D.; Ku, G.; Ilson, D.; Janjigian, Y. Y.; Wu, A.; Schoder, H.; Goodman, K. A.
    British Journal of Cancer (2015)

    Fulltext@MSK | Save